From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning
How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease?
Clark E. Tedford tells us about his part in creating LumiThera, its flagship product and technology, and the company’s plans for the future
The retinal pigment epithelial patch edges closer to becoming a reality for dry AMD patients
The standard of care for wet AMD presents a big burden for patients, so what other options are out there?
Michael D. Abramoff,
Four deep learning experts discuss the ethical implications of using advanced technologies in eye care – and potential solutions
A newly-identified mutation in monkeys could spur development of cell and gene therapies for BBS
Could the ELOVL2 gene be the key to new therapeutics for age-related eye diseases?
A round-up of this month’s acquisitions, approvals and the beginning of Ophthovation…
25 retina specialists, one pioneering model for international collaboration – this is the story of the International Retina Group
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.